RXi expands intellectual property portfolio with additional NeuVax patents

[News]

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that it expanded its patent portfolio with additional patents covering worldwide rights to develop and commercialize NeuVax.

More... (http://www.news-medical.net/news/20110714/RXi-expands-intellectual-property-portfolio-with-additional-NeuVax-patents.aspx)